06:01:39 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande


2023-02-24 Bokslutskommuniké 2022
2022-11-25 Kvartalsrapport 2022-Q3
2022-08-26 Kvartalsrapport 2022-Q2
2022-05-27 Kvartalsrapport 2022-Q1
2022-05-06 Ordinarie utdelning POLAR 0.00 SEK
2022-05-05 Årsstämma 2022
2022-02-25 Bokslutskommuniké 2021
2021-11-26 Kvartalsrapport 2021-Q3
2021-08-27 Kvartalsrapport 2021-Q2
2021-05-28 Kvartalsrapport 2021-Q1
2021-05-06 Ordinarie utdelning POLAR 0.00 SEK
2021-05-05 Årsstämma 2021
2021-02-26 Bokslutskommuniké 2020
2020-11-27 Kvartalsrapport 2020-Q3
2020-08-28 Kvartalsrapport 2020-Q2
2020-07-01 Ordinarie utdelning POLAR 0.00 SEK
2020-06-30 Årsstämma 2020
2020-05-29 Kvartalsrapport 2020-Q1
2020-02-28 Bokslutskommuniké 2019
2020-02-14 Extra Bolagsstämma 2020
2019-10-23 Kvartalsrapport 2019-Q3
2019-07-24 Kvartalsrapport 2019-Q2
2019-05-07 Split POLAR 16:1
2019-04-26 Kvartalsrapport 2019-Q1
2019-03-19 Årsstämma 2019
2019-02-04 Ordinarie utdelning POLAR 0.00 SEK
2019-02-01 Bokslutskommuniké 2018


Polarcool är verksamma inom medicinteknik. Idag är bolaget inriktade mot att produkter och lösningar inriktade för skador inom sport och aktivitet. Störst fokus återfinns inom forskning och utveckling av produkter som används vid behandling av hjärnskador vid exempelvis boxning, rugby och amerikansk fotboll. Verksamhet innehas på global nivå, med störst närvaro inom den europeiska marknaden.
2022-05-02 13:31:00

Aalborg Handball become the first Danish team to sign a trial agreement with PolarCool AB (publ) for use of the PolarCap® System, an acute treatment for concussion. The agreement marks another important milestone for PolarCool within both a new country and market.

PolarCool AB (publ) develops and markets the portable cooling device PolarCap® System, focusing on acute treatment of concussive and sub-concussive brain injury. PolarCool have recently landed most of its strategic agreements within Europe, yet aims to continue to broaden its presence in the Nordic market.

Aalborg Handball will use the PolarCap® System for the rest of the current season in an initial evaluation period, with the option to continue into a two-year commercial agreement following the evaluation.

Aalborg Handball have a rich history of success in both Danish and European Handball, and the Aalborg brand is one of the most recognized within the Danish sports market. The team have won 6 Danish Championships and 2 Danish Cups. During the 2021 season they reached the final of the EHF Champions League. 

Aalborg Handball physiotherapist Rasmus Nyman comments:

- I am glad that Aalborg Handball as an organization, becomes the first handball team in Denmark to make the PolarCap® System available to our players. The scientific evidence regarding the treatment effects are impressive and we now look forward to getting first-hand experience of using the device.

PolarCool's CEO Erik Andersson comments:

- It feels exciting to continue the establishment in handball for PolarCap®, not least in the Nordic market. That Aalborg Handball now will start including PolarCap® in its management routines for concussions once again shows the width of the market for PolarCap®. Our hope is that this will lead to more attention for PolarCap® on the Danish market, both in handball but also in football and ice hockey.

PolarCool AB (publ) continues to focus on top clubs and leagues with the aim to further establish PolarCap® as a concussion treatment solution across Europe. Handball is one of the most popular team sports for males and females in much of Europe. PolarCool have with this agreement entered agreements with top clubs in Sweden, France and now Denmark.